Cardiovascular Disease

The viral vectors market is evolving with advancements in gene therapy and vaccine technologies. New developments are enabling viral vectors to produce stable, non-toxic, and safe therapeutic outcomes. As the industry moves towards standardized and automated manufacturing processes, the potential for viral vectors in treating cancers, genetic diseases, and other conditions continues to grow. Kalorama…

The medical device industry faces unique challenges and opportunities, especially highlighted during the events of 2020. This heavily regulated industry must navigate approval and reimbursement processes, often influenced by group purchasing organizations and government negotiations. Companies are driven to invest continuously in research and development to innovate and succeed. Despite these challenges, the industry benefits…

For further details and to purchase directly, please contact us.

Biomarkers are biological or biochemical molecules, genetic changes, or other measurable characteristics that indicate or predict a condition, risk, or likely biological response. They have a wide range of diagnostic applications, including predicting disease risk, diagnosis, prognosis, identifying appropriate therapy, and monitoring disease or its recurrence.

Kalorama Information’s World Market for Biomarkers (Cardiac [cTn, HscTn,…